Dr. Giordano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1999 - 2002
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2027
- GA State Medical License 2023 - 2027
- TN State Medical License 2023 - 2027
- LA State Medical License 2023 - 2026
- OK State Medical License 2020 - 2026
- TX State Medical License 1999 - 2026
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Male Breast Cancer: Understanding the Biology for Improved Patient Care Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Use of adjuvant capecitabine in older patients with early-stage triple-negative breast cancer.Marija Sullivan, Xiudong Lei, Meghan Karuturi, Catalina Malinowski, Sharon H Giordano
Breast Cancer Research and Treatment. 2025-05-01 - Treatment Patterns, Trends, and Outcomes of Neoadjuvant Chemotherapy Use Among Patients With Early-Stage Invasive Triple-Negative Breast Cancer.Inimfon Jackson, Xiudong Lei, Catalina Malinowski, Sharon H Giordano, Mariana Chavez-MacGregor
JCO Oncology Practice. 2025-03-24 - 4 citationsOptimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights.Jennifer L Caswell-Jin, Rachel A Freedman, Michael J Hassett, Hao Tang, Elizabeth Garrett-Mayer
JCO Oncology Practice. 2025-03-01
Journal Articles
- Association of Chemotherapy with Survival in Elderly Patients with Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast CancerSharon Giordano, MD, JAMA Oncology
Press Mentions
- Can Men Get Breast Cancer? 10 Things to KnowOctober 1st, 2024
- Pausing Endocrine Therapy to Attempt Pregnancy Is SafeMay 8th, 2023
- Breast Cancer Survivors Can Safely Interrupt Therapy During Pregnancy: StudyMay 4th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: